Standard Biotools Inc (LAB) — Cash Flow-to-Debt Ratio
Standard Biotools Inc (LAB) has a Cash Flow-to-Debt Ratio of -0.12x as of June 2026, meaning its operating cash flow of $-10.31 Million could theoretically repay 0% of its total liabilities ($87.25 Million) in one year. See Standard Biotools Inc (LAB) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Standard Biotools Inc Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for Standard Biotools Inc across 20 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Standard Biotools Inc.
Annual Cash Flow-to-Debt Ratio for Standard Biotools Inc (2006–2025)
Year-by-year debt coverage analysis for Standard Biotools Inc. Check Standard Biotools Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.52x | $-74.35 Million | $143.46 Million | ▲ +49.2% |
| 2024 | -1.02x | $-143.45 Million | $140.62 Million | ▼ -1010.3% |
| 2023 | -0.09x | $-43.29 Million | $471.12 Million | ▲ +51.5% |
| 2022 | -0.19x | $-89.37 Million | $471.78 Million | ▲ +22.3% |
| 2021 | -0.24x | $-44.06 Million | $180.62 Million | ▼ -193.8% |
| 2020 | -0.08x | $-15.42 Million | $185.71 Million | ▲ +73.8% |
| 2019 | -0.32x | $-35.21 Million | $111.20 Million | ▼ -190.9% |
| 2018 | -0.11x | $-25.20 Million | $231.53 Million | ▼ -15.8% |
| 2017 | -0.09x | $-24.10 Million | $256.42 Million | ▲ +39.1% |
| 2016 | -0.15x | $-39.10 Million | $253.16 Million | ▼ -14.0% |
| 2015 | -0.14x | $-34.70 Million | $256.16 Million | ▼ -54.0% |
| 2014 | -0.09x | $-22.62 Million | $257.14 Million | ▼ -9.5% |
| 2013 | -0.08x | $-1.59 Million | $19.80 Million | ▲ +94.0% |
| 2012 | -1.34x | $-17.48 Million | $13.07 Million | ▼ -70.9% |
| 2011 | -0.78x | $-17.54 Million | $22.43 Million | ▼ -1354.2% |
| 2010 | -0.05x | $-11.51 Million | $213.97 Million | ▲ +43.3% |
| 2009 | -0.09x | $-19.51 Million | $205.77 Million | ▲ +37.0% |
| 2008 | -0.15x | $-28.72 Million | $190.69 Million | ▼ -28.1% |
| 2007 | -0.12x | $-21.76 Million | $185.11 Million | ▲ +24.8% |
| 2006 | -0.16x | $-22.31 Million | $142.66 Million | — |